Previous 10 | Next 10 |
Evolent Health, Inc. to Release First Quarter Operating Results and Host Conference Call on Wednesday, May 4, 2022 PR Newswire WASHINGTON , April 18, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinica...
Evolent Health recently reported their Q4/2021 earnings that revealed a solid beat on EPS and revenue. In addition, the company updated investors on their bullish outlook for 2022. The company is working on their 3 primary objectives of strong organic growth, expanding margins, and op...
The following slide deck was published by Evolent Health, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Evolent Health, Inc. 2021 Q4 - Results - Earnings Call Presentation
Allscripts Healthcare Solutions is finally showing some robust fundamental results after a few difficult years. This is great news for investors, as is the fact that shares are cheap enough to imply some nice upside moving forward. That said, consistency is still lacking and that ...
Shares of Evolent Health (NYSE: EVH) rose more than 22% in early trading Thursday. The healthcare services stock, which closed at $22.21 on Wednesday, opened at $24.37 on Thursday and rose to a high of $27.03 in the first hour of trading. The stock has a 52-week low of $17.50 and a ...
Evolent Health (EVH +16.1%) has added more than a tenth on Thursday morning hours to record the biggest intraday gain since July 2020, after the health tech company posted better-than-expected financials for Q4 2021 and set its guidance ahead of Street forecasts. Quarterly revenue on a G...
Gainers: Lantheus (NASDAQ:LNTH) +34%. Evolent Health (NYSE:EVH) +18%. Clover Health (NASDAQ:CLOV) +10%. Liquidia (NASDAQ:LQDA) +10%. iRhythm Technologies (NASDAQ:IRTC) +8%. Losers: Orphazyme (NASDAQ:ORPH) -36%. Rhythm Pharmaceuticals (NASDAQ:RYTM) -24%. Tabu...
Image source: The Motley Fool. Evolent Health (NYSE: EVH) Q4 2021 Earnings Call Feb 23, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Evolent Health (EVH) Q4 2021 Earnings Call Transcript
Evolent Health, Inc. (EVH) Q4 2021 Results Conference Call February 23, 2022 5:00 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Seth Frank - Vice President of Investor Relations Conference Call Participants Ryan Daniels - William Bla...
Evolent Health press release (NYSE:EVH): Q4 Non-GAAP EPS of $0.08 beats by $0.07. Revenue of $248.36M (-8.7% Y/Y) beats by $11.88M. For further details see: Evolent Health Non-GAAP EPS of $0.08 beats by $0.07, revenue of $248.36M beats by $11.88M
News, Short Squeeze, Breakout and More Instantly...
Evolent Health Inc Class A Company Name:
EVH Stock Symbol:
NYSE Market:
Evolent Health Inc Class A Website:
Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 PR Newswire Company to Participate in Upcoming Conferences WASHINGTON , July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in bett...
Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify PR Newswire Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-e...
2024-05-09 22:30:13 ET Image source: The Motley Fool. Evolent Health (NYSE: EVH) Q1 2024 Earnings Call May 09, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: Evolent Health (EVH) Q1 2024 Earnings Call Transcript